All Cancer Microbiology articles
-
News
Fecal matter transplant helped patients with gastrointestinal cancers overcome resistance to immunotherapy treatment
Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers.
-
News
Panel issues first guidelines to prevent anal cancer in people with HIV
Results from a national study have informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.
-
News
Study shows ancient viruses fuel modern-day cancers
When reawakened, endogenous retroviruses can play a critical role in helping cancer survive and thrive. A new study also suggests that silencing certain endogenous retroviruses can make cancer treatments work better.
-
News
Researchers develop noninvasive urine test for early detection of cervical cancer virus proteins
A new urine test can detect HPV16 E7 proteins, which are critical markers of cervical cancer risk, at extremely low levels, meaning women may be able to screen for cervical cancer without the discomfort and inconvenience of a traditional Pap test.
-
Careers
Connecting with microbiologists and presenting research: Oluwole Owoyemi reports back from ASM 2024
Medical microbiologist Oluwole Owoyemi of Achievers University Owo and Federal University of Technology, Akure, reports back from ASM MICROBE 2024 after being awarded a Scientific Event Travel Grant by Applied Microbiology International.
-
News
Cancer drug could be repurposed to fight Covid-19
Twelve years ago, cancer researchers identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that the same molecule does the same thing in lung tissue infected with COVID-19.
-
News
Changing the gut microbiome boosts health outcomes for people newly diagnosed with metastatic kidney cancer
Researchers have developed a novel use of biotherapeutic product CBM588 in the treatment of cancer; new research suggests the agent adjusts people’s microbiome, possibly leading to enhanced effectiveness of FDA-approved cancer immunotherapies.
-
News
Breakthrough research makes cancer-fighting viral agent more effective
Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.
-
News
Researchers harness intratumoral microbiome against colorectal cancer
Scientists have established a microbiota-targeted drug delivery system that exhibits high efficiency in colorectal cancer targeting and colon retention.
-
News
Researchers deploy E coli to selectively target tumor cells
Scientists explore how an engineered bacterium limits tumor growth and maximizes targeted anticancer drug delivery.
-
News
Chemotherapy disrupts gut microbiome in patients with breast cancer
Patients treated with chemotherapy who showed decreases in cognitive performance also had reductions in the diversity of their gut microbiome, a new study has found.
-
News
Oncolytic virus inhibits liver cancer growth by inducing cell cycle arrest and apoptosis
Researchers have found that administration of an oncolytic virus, Senecavirus A, effectively suppressed hepatocellular carcinoma proliferation and growth in a mouse model placed beneath the skin by triggering apoptosis.
-
News
Scientists map role of Porphyromonas gingivalis in chemotherapy resistance
A new paper describes how the bacterium Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant to the drug’s effects.
-
News
Researchers advise strengthening immunity against COVID-19 in people with cancer
Researchers who led a study on the effectiveness of vaccines against COVID-19 among cancer patients in Catalonia, have recommended administering additional doses of the vaccine among this risk population.
-
News
Safer virus helps eliminate cancer and protect against future tumors
Scientists have discovered that an attenuated (weakened) virus can help eliminate cancer in mice. In addition, mice that were treated with this virus were more resistant to developing tumors later in life.
-
News
Epstein-Barr virus can trigger quicker growth of nasopharyngeal cancer
Scientists have shown how the Epstein-Barr virus (EBV) alters how specific genes are regulated, making nasopharyngeal cancer tumours (NPC) grow faster.
-
News
Lung microbiomes predict mortality in children following bone marrow transplant
Using a method that identifies all potentially pathogenic organisms present in the lungs, scientists have discovered links between certain microbial communities and the relative risk of mortality in children who undergo bone marrow transplants.
-
News
Antibacterial protein offers new therapeutic target against pancreatic cancer
A recent study describes how pancreatic cancer stem cells take advantage of an antibacterial protein, PGLYRP1, to evade the immune system and protect themselves from early elimination.
-
News
Specific microbial hallmarks in vagina could indicate gynecological cancers
A new study demonstrates unique vaginal microbiome in patients with gynecological cancers which could function as a biomarker.
-
News
New viral strain induces immunogenic cell death in tumour cells
A study has developed a new strain of vaccinia virus, which can replicate in tumour cells while maintaining increased immunogenicity. Specifically, it can to induce so-called immunogenic cell death in tumour cells.